Catalysts for Bionpharma Inc
80 tracked
Apr 8, 2026
approval
VALPROIC ACID โ FDA approval
VALPROIC ACID
โ
Mar 31, 2026
approval
STAVZOR (VALPROIC ACID) โ FDA approval
VALPROIC ACID
โ
Mar 2, 2026
approval
IMODIUM MULTI-SYMPTOM RELIEF (LOPERAMIDE HYDROCHLORIDE) โ FDA approval
Bionpharma Inc
โ
Jan 30, 2026
approval
CETIRIZINE HYDROCHLORIDE ALLERGY (CETIRIZINE HYDROCHLORIDE) โ FDA approval
CETIRIZINE HYDROCHLORIDE
โ
Jan 15, 2026
approval
NAPROXEN SODIUM โ FDA approval
NAPROXEN SODIUM
โ
Dec 23, 2025
approval
GLYCOPYRROLATE โ FDA approval
GLYCOPYRROLATE
โ
Oct 2, 2025
approval
ETRAVIRINE โ FDA approval
ETRAVIRINE
โ
Sep 19, 2025
approval
LOPERAMIDE HYDROCHLORIDE โ FDA approval
LOPERAMIDE HYDROCHLORIDE
โ
Jan 14, 2022
approval
VALPROIC ACID โ FDA approval
VALPROIC ACID
โ
Jan 14, 2022
approval
VALPROIC ACID โ FDA approval
VALPROIC ACID
โ
Dec 13, 2021
approval
NAPROXEN SODIUM โ FDA approval
NAPROXEN SODIUM
โ
Nov 30, 2021
approval
STAVZOR (VALPROIC ACID) โ FDA approval
VALPROIC ACID
โ
Dec 12, 2020
approval
NAPROXEN SODIUM โ FDA approval
NAPROXEN SODIUM
โ
Dec 7, 2020
approval
CETIRIZINE HYDROCHLORIDE ALLERGY (CETIRIZINE HYDROCHLORIDE) โ FDA approval
CETIRIZINE HYDROCHLORIDE
โ
Apr 30, 2020
approval
NAPROXEN SODIUM โ FDA approval
NAPROXEN SODIUM
โ
Feb 27, 2020
approval
NAPROXEN SODIUM โ FDA approval
NAPROXEN SODIUM
โ
Dec 26, 2019
approval
STAVZOR (VALPROIC ACID) โ FDA approval
VALPROIC ACID
โ
Dec 13, 2019
approval
CETIRIZINE HYDROCHLORIDE ALLERGY (CETIRIZINE HYDROCHLORIDE) โ FDA approval
CETIRIZINE HYDROCHLORIDE
โ
Dec 9, 2019
approval
NAPROXEN SODIUM โ FDA approval
NAPROXEN SODIUM
โ
Dec 9, 2019
approval
VALPROIC ACID โ FDA approval
VALPROIC ACID
โ
Dec 9, 2019
approval
VALPROIC ACID โ FDA approval
VALPROIC ACID
โ
Dec 9, 2019
approval
VALPROIC ACID โ FDA approval
VALPROIC ACID
โ
Dec 9, 2019
approval
VALPROIC ACID โ FDA approval
VALPROIC ACID
โ
Dec 9, 2019
approval
VALPROIC ACID โ FDA approval
VALPROIC ACID
โ
Oct 26, 2019
approval
NAPROXEN SODIUM โ FDA approval
NAPROXEN SODIUM
โ
Feb 20, 2019
approval
NAPROXEN SODIUM โ FDA approval
NAPROXEN SODIUM
โ
Dec 11, 2018
approval
IMODIUM MULTI-SYMPTOM RELIEF (LOPERAMIDE HYDROCHLORIDE) โ FDA approval
Bionpharma Inc
โ
Nov 29, 2018
approval
NAPROXEN SODIUM โ FDA approval
NAPROXEN SODIUM
โ
Apr 12, 2017
approval
IMODIUM MULTI-SYMPTOM RELIEF (LOPERAMIDE HYDROCHLORIDE) โ FDA approval
Bionpharma Inc
โ
Mar 16, 2017
approval
NAPROXEN SODIUM โ FDA approval
NAPROXEN SODIUM
โ